Clinical Study of Low-dose 64-MDCT Perfusion Imaging in the Evaluation of Patients with Non-small Cell Lung Cancer

JIN Biao,WANG Yong-jie,ZOU Ming,BIAN Liu-li,YAO Li-hua
DOI: https://doi.org/10.19627/j.cnki.cn31-1700/th.2013.04.007
2013-01-01
Abstract:Purpose: To explore the clinical value of low-dose 64-MDCT perfusion imaging in the evaluation of patients with non-small cell lung cancer.Methods: Forty cases with non-small cell lung cancer verifed by pathology results were divided into two groups randomly.These 2 groups were undergone routine dose(80kV,160mAs)and low-dose(80kV,50mAs)MDCT perfusion scanning.The original images were processed by perfusion software.The value of blood fow(BF),blood volume(BV) and permeability(PMB) were calculated.Paired t test was used to compare the values of these two groups.The radiation dosage,which the patients in the two groups received,was also calculated.Results: The differences of BF,BV and PMB between two groups were not shown with statistical significance(P>0.05).The radiation dosage of the low-dose group was much lower than that of the routine dose group.The value of CTDIvol and DLP was decreased by 68.56% and 68.63%,respectively.Conclusion: Low-dose MDCT perfusion imaging plays a valuable role in the assessment of clinical diagnosis,pre-operation staging,post-operation checkup,pre and post radiation or chemical therapy response evaluation of non-small cell lung cancer.
What problem does this paper attempt to address?